Up-regulation of endogenous TrxR1 has been reported in several cancer cells, such as breast cancer and lung cancer, indicating an important role of TrxR1 in sustaining tumor phenotypes, and TrxR1 is regarded as a potential target for cancer chemotherapy [8]. Here, TXNRD1 is linked to breast carcinoma.